SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001654954-19-000496
Filing Date
2019-01-15
Accepted
2019-01-15 16:16:55
Documents
4
Period of Report
2019-01-10
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT vtgn8k_jan102019.htm 8-K 29291
2 INDEMNIFICATION AGREEMENT, DATED JANUARY 10, 2019, BY AND BETWEEN VISTAGEN THERA ex10-1.htm EX-10.1 61040
3 PRESS RELEASE, DATED JANUARY 15, 2019 ex99-1.htm EX-99.1 19052
4 IMAGE vtgn.jpg GRAPHIC 6742
  Complete submission text file 0001654954-19-000496.txt   120116
Mailing Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-577-3600
VistaGen Therapeutics, Inc. (Filer) CIK: 0001411685 (see all company filings)

IRS No.: 205093315 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-37761 | Film No.: 19527275
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1